New diabetes clinical trial: Teplizumab in Pediatric Stage 2 Type 1 Diabetes

Published on: March 07, 2023 at 11:00AM
Condition:   Type 1 Diabetes
Intervention:   Biological: teplizumab
Sponsor:   Provention Bio, Inc.
Not yet recruiting
https://ift.tt/59EAaDQ